Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-sparing Therapy for Recurrent High-grade Non–muscle-invasive Bladder Cancer: Recurrent High-risk NMIBC: One Bladder, Choose Wisely
Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-sparing Therapy for Recurrent High-grade Non–muscle-invasive Bladder Cancer: Recurrent High-risk NMIBC: One Bladder, Choose Wisely. // European Urology. – URL: https://www.sciencedirect.com/science/article/pii/S0302283826021810?dgcid=rss_sd_all
Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-sparing Therapy for Recurrent High-grade Non–muscle-invasive Bladder Cancer: Recurrent High-risk NMIBC: One Bladder, Choose Wisely. European Urology. https://www.sciencedirect.com/science/article/pii/S0302283826021810?dgcid=rss_sd_all
“Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-sparing Therapy for Recurrent High-grade Non–muscle-invasive Bladder Cancer: Recurrent High-risk NMIBC: One Bladder, Choose Wisely.” European Urology.
@article{article107535,
title = {Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-sparing Therapy for Recurrent High-grade Non–muscle-invasive Bladder Cancer: Recurrent High-risk NMIBC: One Bladder, Choose Wisely},
journal = {European Urology},
url = {https://www.sciencedirect.com/science/article/pii/S0302283826021810?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...